Skip to Content

Pfizer JKI 10 (Xeljanz 10 mg)

Generic Name: tofacitinib

Pill with imprint Pfizer JKI 10 is Blue, Round and has been identified as Xeljanz 10 mg. It is supplied by Pfizer Inc..

Xeljanz is used in the treatment of rheumatoid arthritis; ulcerative colitis; psoriatic arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer JKI 10

Xeljanz 10 mg Pfizer JKI 10

Xeljanz

Generic Name
tofacitinib
Imprint
Pfizer JKI 10
Strength
10 mg
Color
Blue
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antirheumatics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-1002
Inactive Ingredients
microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, magnesium stearate, titanium dioxide, triacetin, polyethylene glycol 3350, hypromellose 2910 (6 mPa.s), FD&C Blue No. 1, FD&C Blue No. 2

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.